nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—Parkinson's disease—Diphenhydramine—atopic dermatitis	0.712	1	CpDpCtD
Cabergoline—CYP3A4—Pimecrolimus—atopic dermatitis	0.013	0.258	CbGbCtD
Cabergoline—DRD5—eyelid—atopic dermatitis	0.0104	0.548	CbGeAlD
Cabergoline—CYP3A4—Tacrolimus—atopic dermatitis	0.00772	0.153	CbGbCtD
Cabergoline—CYP3A4—Loratadine—atopic dermatitis	0.00565	0.112	CbGbCtD
Cabergoline—CYP3A4—Methylprednisolone—atopic dermatitis	0.00517	0.103	CbGbCtD
Cabergoline—CYP3A4—Triamcinolone—atopic dermatitis	0.00392	0.0778	CbGbCtD
Cabergoline—CYP3A4—Betamethasone—atopic dermatitis	0.00336	0.0667	CbGbCtD
Cabergoline—CYP3A4—Prednisolone—atopic dermatitis	0.00332	0.0658	CbGbCtD
Cabergoline—CYP3A4—Hydrocortisone—atopic dermatitis	0.00314	0.0624	CbGbCtD
Cabergoline—CYP3A4—Prednisone—atopic dermatitis	0.00313	0.0622	CbGbCtD
Cabergoline—CYP3A4—Dexamethasone—atopic dermatitis	0.00195	0.0388	CbGbCtD
Cabergoline—HTR7—neck—atopic dermatitis	0.000741	0.0391	CbGeAlD
Cabergoline—DRD3—head—atopic dermatitis	0.000699	0.0369	CbGeAlD
Cabergoline—DRD5—head—atopic dermatitis	0.000655	0.0346	CbGeAlD
Cabergoline—HTR2B—skin of body—atopic dermatitis	0.00056	0.0296	CbGeAlD
Cabergoline—ADRA1B—head—atopic dermatitis	0.000537	0.0284	CbGeAlD
Cabergoline—ADRA1D—head—atopic dermatitis	0.000525	0.0277	CbGeAlD
Cabergoline—DRD1—head—atopic dermatitis	0.000501	0.0264	CbGeAlD
Cabergoline—HTR2A—neck—atopic dermatitis	0.000462	0.0244	CbGeAlD
Cabergoline—HTR1B—head—atopic dermatitis	0.000406	0.0214	CbGeAlD
Cabergoline—HTR1D—head—atopic dermatitis	0.000393	0.0207	CbGeAlD
Cabergoline—HTR2C—head—atopic dermatitis	0.000389	0.0205	CbGeAlD
Cabergoline—ADRB1—head—atopic dermatitis	0.000382	0.0202	CbGeAlD
Cabergoline—HTR2B—head—atopic dermatitis	0.000365	0.0193	CbGeAlD
Cabergoline—HTR1A—head—atopic dermatitis	0.000327	0.0173	CbGeAlD
Cabergoline—HTR7—head—atopic dermatitis	0.000313	0.0165	CbGeAlD
Cabergoline—ADRA1A—head—atopic dermatitis	0.000302	0.0159	CbGeAlD
Cabergoline—DRD2—head—atopic dermatitis	0.000296	0.0156	CbGeAlD
Cabergoline—ADRA2C—head—atopic dermatitis	0.000288	0.0152	CbGeAlD
Cabergoline—ADRA2A—head—atopic dermatitis	0.000229	0.0121	CbGeAlD
Cabergoline—HTR2A—head—atopic dermatitis	0.000195	0.0103	CbGeAlD
Cabergoline—Hallucination—Methylprednisolone—atopic dermatitis	0.000161	0.00113	CcSEcCtD
Cabergoline—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.00016	0.00112	CcSEcCtD
Cabergoline—Arrhythmia—Prednisolone—atopic dermatitis	0.000158	0.0011	CcSEcCtD
Cabergoline—Vomiting—Mometasone—atopic dermatitis	0.000157	0.0011	CcSEcCtD
Cabergoline—Sweating increased—Prednisone—atopic dermatitis	0.000156	0.00109	CcSEcCtD
Cabergoline—Visual impairment—Methylprednisolone—atopic dermatitis	0.000156	0.00109	CcSEcCtD
Cabergoline—Rash—Mometasone—atopic dermatitis	0.000155	0.00109	CcSEcCtD
Cabergoline—Dermatitis—Mometasone—atopic dermatitis	0.000155	0.00109	CcSEcCtD
Cabergoline—Abdominal pain—Tacrolimus—atopic dermatitis	0.000155	0.00108	CcSEcCtD
Cabergoline—Headache—Mometasone—atopic dermatitis	0.000154	0.00108	CcSEcCtD
Cabergoline—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000154	0.00108	CcSEcCtD
Cabergoline—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000153	0.00107	CcSEcCtD
Cabergoline—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.00015	0.00105	CcSEcCtD
Cabergoline—Hallucination—Dexamethasone—atopic dermatitis	0.000146	0.00102	CcSEcCtD
Cabergoline—Hallucination—Betamethasone—atopic dermatitis	0.000146	0.00102	CcSEcCtD
Cabergoline—Nausea—Mometasone—atopic dermatitis	0.000146	0.00102	CcSEcCtD
Cabergoline—Weight increased—Prednisone—atopic dermatitis	0.000146	0.00102	CcSEcCtD
Cabergoline—Arrhythmia—Triamcinolone—atopic dermatitis	0.000145	0.00101	CcSEcCtD
Cabergoline—Weight decreased—Prednisone—atopic dermatitis	0.000145	0.00101	CcSEcCtD
Cabergoline—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000145	0.00101	CcSEcCtD
Cabergoline—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000145	0.00101	CcSEcCtD
Cabergoline—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000142	0.000996	CcSEcCtD
Cabergoline—Depression—Prednisone—atopic dermatitis	0.000142	0.000995	CcSEcCtD
Cabergoline—Visual impairment—Dexamethasone—atopic dermatitis	0.000142	0.000991	CcSEcCtD
Cabergoline—Visual impairment—Betamethasone—atopic dermatitis	0.000142	0.000991	CcSEcCtD
Cabergoline—Asthenia—Tacrolimus—atopic dermatitis	0.000141	0.000984	CcSEcCtD
Cabergoline—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000139	0.000973	CcSEcCtD
Cabergoline—Pruritus—Tacrolimus—atopic dermatitis	0.000139	0.00097	CcSEcCtD
Cabergoline—Malaise—Prednisolone—atopic dermatitis	0.000138	0.000968	CcSEcCtD
Cabergoline—Vertigo—Prednisolone—atopic dermatitis	0.000138	0.000964	CcSEcCtD
Cabergoline—Syncope—Prednisolone—atopic dermatitis	0.000138	0.000963	CcSEcCtD
Cabergoline—Back pain—Triamcinolone—atopic dermatitis	0.000137	0.000955	CcSEcCtD
Cabergoline—Malaise—Hydrocortisone—atopic dermatitis	0.000135	0.000945	CcSEcCtD
Cabergoline—Loss of consciousness—Prednisolone—atopic dermatitis	0.000135	0.000943	CcSEcCtD
Cabergoline—Vertigo—Hydrocortisone—atopic dermatitis	0.000135	0.000942	CcSEcCtD
Cabergoline—Syncope—Hydrocortisone—atopic dermatitis	0.000134	0.00094	CcSEcCtD
Cabergoline—Diarrhoea—Tacrolimus—atopic dermatitis	0.000134	0.000938	CcSEcCtD
Cabergoline—Hypertension—Prednisolone—atopic dermatitis	0.000133	0.000927	CcSEcCtD
Cabergoline—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000132	0.000921	CcSEcCtD
Cabergoline—Arrhythmia—Dexamethasone—atopic dermatitis	0.000131	0.000919	CcSEcCtD
Cabergoline—Arrhythmia—Betamethasone—atopic dermatitis	0.000131	0.000919	CcSEcCtD
Cabergoline—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000131	0.000916	CcSEcCtD
Cabergoline—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000131	0.000914	CcSEcCtD
Cabergoline—Alopecia—Betamethasone—atopic dermatitis	0.00013	0.000909	CcSEcCtD
Cabergoline—Alopecia—Dexamethasone—atopic dermatitis	0.00013	0.000909	CcSEcCtD
Cabergoline—Dizziness—Tacrolimus—atopic dermatitis	0.00013	0.000907	CcSEcCtD
Cabergoline—Hypertension—Hydrocortisone—atopic dermatitis	0.000129	0.000905	CcSEcCtD
Cabergoline—Discomfort—Prednisolone—atopic dermatitis	0.000129	0.000903	CcSEcCtD
Cabergoline—Hallucination—Prednisone—atopic dermatitis	0.000128	0.000891	CcSEcCtD
Cabergoline—Malaise—Triamcinolone—atopic dermatitis	0.000127	0.00089	CcSEcCtD
Cabergoline—Anxiety—Hydrocortisone—atopic dermatitis	0.000127	0.000889	CcSEcCtD
Cabergoline—Malaise—Methylprednisolone—atopic dermatitis	0.000127	0.000888	CcSEcCtD
Cabergoline—Vertigo—Triamcinolone—atopic dermatitis	0.000127	0.000887	CcSEcCtD
Cabergoline—Syncope—Triamcinolone—atopic dermatitis	0.000127	0.000885	CcSEcCtD
Cabergoline—Vertigo—Methylprednisolone—atopic dermatitis	0.000127	0.000885	CcSEcCtD
Cabergoline—Syncope—Methylprednisolone—atopic dermatitis	0.000126	0.000883	CcSEcCtD
Cabergoline—Discomfort—Hydrocortisone—atopic dermatitis	0.000126	0.000882	CcSEcCtD
Cabergoline—Oedema—Prednisolone—atopic dermatitis	0.000125	0.000876	CcSEcCtD
Cabergoline—Vomiting—Tacrolimus—atopic dermatitis	0.000125	0.000872	CcSEcCtD
Cabergoline—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000124	0.000868	CcSEcCtD
Cabergoline—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000124	0.000866	CcSEcCtD
Cabergoline—Rash—Tacrolimus—atopic dermatitis	0.000124	0.000865	CcSEcCtD
Cabergoline—Dermatitis—Tacrolimus—atopic dermatitis	0.000124	0.000864	CcSEcCtD
Cabergoline—Shock—Prednisolone—atopic dermatitis	0.000123	0.000862	CcSEcCtD
Cabergoline—Headache—Tacrolimus—atopic dermatitis	0.000123	0.000859	CcSEcCtD
Cabergoline—Oedema—Hydrocortisone—atopic dermatitis	0.000122	0.000856	CcSEcCtD
Cabergoline—Hypertension—Triamcinolone—atopic dermatitis	0.000122	0.000852	CcSEcCtD
Cabergoline—Hypertension—Methylprednisolone—atopic dermatitis	0.000122	0.00085	CcSEcCtD
Cabergoline—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000121	0.000847	CcSEcCtD
Cabergoline—Shock—Hydrocortisone—atopic dermatitis	0.00012	0.000842	CcSEcCtD
Cabergoline—Arthralgia—Methylprednisolone—atopic dermatitis	0.00012	0.000838	CcSEcCtD
Cabergoline—Anxiety—Methylprednisolone—atopic dermatitis	0.00012	0.000836	CcSEcCtD
Cabergoline—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000119	0.000831	CcSEcCtD
Cabergoline—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000119	0.000831	CcSEcCtD
Cabergoline—Discomfort—Triamcinolone—atopic dermatitis	0.000119	0.00083	CcSEcCtD
Cabergoline—Discomfort—Methylprednisolone—atopic dermatitis	0.000119	0.000828	CcSEcCtD
Cabergoline—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000118	0.000827	CcSEcCtD
Cabergoline—Dry mouth—Triamcinolone—atopic dermatitis	0.000118	0.000822	CcSEcCtD
Cabergoline—Anorexia—Hydrocortisone—atopic dermatitis	0.000117	0.000816	CcSEcCtD
Cabergoline—Nausea—Tacrolimus—atopic dermatitis	0.000117	0.000815	CcSEcCtD
Cabergoline—Confusional state—Methylprednisolone—atopic dermatitis	0.000116	0.00081	CcSEcCtD
Cabergoline—Malaise—Betamethasone—atopic dermatitis	0.000116	0.000808	CcSEcCtD
Cabergoline—Malaise—Dexamethasone—atopic dermatitis	0.000116	0.000808	CcSEcCtD
Cabergoline—Oedema—Triamcinolone—atopic dermatitis	0.000115	0.000806	CcSEcCtD
Cabergoline—Vertigo—Dexamethasone—atopic dermatitis	0.000115	0.000805	CcSEcCtD
Cabergoline—Vertigo—Betamethasone—atopic dermatitis	0.000115	0.000805	CcSEcCtD
Cabergoline—Syncope—Dexamethasone—atopic dermatitis	0.000115	0.000803	CcSEcCtD
Cabergoline—Syncope—Betamethasone—atopic dermatitis	0.000115	0.000803	CcSEcCtD
Cabergoline—Arrhythmia—Prednisone—atopic dermatitis	0.000114	0.0008	CcSEcCtD
Cabergoline—Hypotension—Hydrocortisone—atopic dermatitis	0.000114	0.000799	CcSEcCtD
Cabergoline—Shock—Triamcinolone—atopic dermatitis	0.000113	0.000793	CcSEcCtD
Cabergoline—Insomnia—Prednisolone—atopic dermatitis	0.000113	0.000792	CcSEcCtD
Cabergoline—Alopecia—Prednisone—atopic dermatitis	0.000113	0.000792	CcSEcCtD
Cabergoline—Shock—Methylprednisolone—atopic dermatitis	0.000113	0.000791	CcSEcCtD
Cabergoline—Loss of consciousness—Betamethasone—atopic dermatitis	0.000113	0.000787	CcSEcCtD
Cabergoline—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000113	0.000787	CcSEcCtD
Cabergoline—Paraesthesia—Prednisolone—atopic dermatitis	0.000113	0.000787	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000112	0.000779	CcSEcCtD
Cabergoline—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000111	0.000779	CcSEcCtD
Cabergoline—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000111	0.000777	CcSEcCtD
Cabergoline—Insomnia—Hydrocortisone—atopic dermatitis	0.000111	0.000774	CcSEcCtD
Cabergoline—Hypertension—Betamethasone—atopic dermatitis	0.000111	0.000773	CcSEcCtD
Cabergoline—Hypertension—Dexamethasone—atopic dermatitis	0.000111	0.000773	CcSEcCtD
Cabergoline—Paraesthesia—Hydrocortisone—atopic dermatitis	0.00011	0.000768	CcSEcCtD
Cabergoline—Anxiety—Dexamethasone—atopic dermatitis	0.000109	0.00076	CcSEcCtD
Cabergoline—Anxiety—Betamethasone—atopic dermatitis	0.000109	0.00076	CcSEcCtD
Cabergoline—Discomfort—Betamethasone—atopic dermatitis	0.000108	0.000753	CcSEcCtD
Cabergoline—Discomfort—Dexamethasone—atopic dermatitis	0.000108	0.000753	CcSEcCtD
Cabergoline—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000108	0.000753	CcSEcCtD
Cabergoline—Hypotension—Methylprednisolone—atopic dermatitis	0.000107	0.000751	CcSEcCtD
Cabergoline—Pain—Prednisolone—atopic dermatitis	0.000107	0.000749	CcSEcCtD
Cabergoline—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000106	0.000744	CcSEcCtD
Cabergoline—Fatigue—Hydrocortisone—atopic dermatitis	0.000106	0.000738	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000105	0.000734	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000105	0.000732	CcSEcCtD
Cabergoline—Pain—Hydrocortisone—atopic dermatitis	0.000105	0.000732	CcSEcCtD
Cabergoline—Oedema—Dexamethasone—atopic dermatitis	0.000105	0.000731	CcSEcCtD
Cabergoline—Oedema—Betamethasone—atopic dermatitis	0.000105	0.000731	CcSEcCtD
Cabergoline—Insomnia—Triamcinolone—atopic dermatitis	0.000104	0.000729	CcSEcCtD
Cabergoline—Insomnia—Methylprednisolone—atopic dermatitis	0.000104	0.000727	CcSEcCtD
Cabergoline—Ill-defined disorder—Prednisone—atopic dermatitis	0.000104	0.000724	CcSEcCtD
Cabergoline—Paraesthesia—Triamcinolone—atopic dermatitis	0.000103	0.000723	CcSEcCtD
Cabergoline—Feeling abnormal—Prednisolone—atopic dermatitis	0.000103	0.000722	CcSEcCtD
Cabergoline—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000103	0.000722	CcSEcCtD
Cabergoline—Shock—Dexamethasone—atopic dermatitis	0.000103	0.000719	CcSEcCtD
Cabergoline—Shock—Betamethasone—atopic dermatitis	0.000103	0.000719	CcSEcCtD
Cabergoline—Dyspnoea—Triamcinolone—atopic dermatitis	0.000103	0.000718	CcSEcCtD
Cabergoline—Dyspepsia—Triamcinolone—atopic dermatitis	0.000101	0.000709	CcSEcCtD
Cabergoline—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000101	0.000708	CcSEcCtD
Cabergoline—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000101	0.000707	CcSEcCtD
Cabergoline—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000101	0.000707	CcSEcCtD
Cabergoline—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000101	0.000705	CcSEcCtD
Cabergoline—Malaise—Prednisone—atopic dermatitis	0.000101	0.000703	CcSEcCtD
Cabergoline—Vertigo—Prednisone—atopic dermatitis	0.0001	0.000701	CcSEcCtD
Cabergoline—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.0001	0.0007	CcSEcCtD
Cabergoline—Syncope—Prednisone—atopic dermatitis	0.0001	0.000699	CcSEcCtD
Cabergoline—Anorexia—Betamethasone—atopic dermatitis	9.97e-05	0.000697	CcSEcCtD
Cabergoline—Anorexia—Dexamethasone—atopic dermatitis	9.97e-05	0.000697	CcSEcCtD
Cabergoline—Fatigue—Triamcinolone—atopic dermatitis	9.94e-05	0.000695	CcSEcCtD
Cabergoline—Fatigue—Methylprednisolone—atopic dermatitis	9.91e-05	0.000693	CcSEcCtD
Cabergoline—Pain—Triamcinolone—atopic dermatitis	9.85e-05	0.000689	CcSEcCtD
Cabergoline—Loss of consciousness—Prednisone—atopic dermatitis	9.81e-05	0.000686	CcSEcCtD
Cabergoline—Hypotension—Dexamethasone—atopic dermatitis	9.77e-05	0.000683	CcSEcCtD
Cabergoline—Hypotension—Betamethasone—atopic dermatitis	9.77e-05	0.000683	CcSEcCtD
Cabergoline—Abdominal pain—Hydrocortisone—atopic dermatitis	9.67e-05	0.000676	CcSEcCtD
Cabergoline—Hypertension—Prednisone—atopic dermatitis	9.63e-05	0.000673	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	9.53e-05	0.000666	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	9.53e-05	0.000666	CcSEcCtD
Cabergoline—Arthralgia—Prednisone—atopic dermatitis	9.5e-05	0.000664	CcSEcCtD
Cabergoline—Feeling abnormal—Triamcinolone—atopic dermatitis	9.5e-05	0.000664	CcSEcCtD
Cabergoline—Feeling abnormal—Methylprednisolone—atopic dermatitis	9.47e-05	0.000662	CcSEcCtD
Cabergoline—Anxiety—Prednisone—atopic dermatitis	9.47e-05	0.000662	CcSEcCtD
Cabergoline—Insomnia—Betamethasone—atopic dermatitis	9.46e-05	0.000661	CcSEcCtD
Cabergoline—Insomnia—Dexamethasone—atopic dermatitis	9.46e-05	0.000661	CcSEcCtD
Cabergoline—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	9.4e-05	0.000657	CcSEcCtD
Cabergoline—Paraesthesia—Betamethasone—atopic dermatitis	9.39e-05	0.000656	CcSEcCtD
Cabergoline—Paraesthesia—Dexamethasone—atopic dermatitis	9.39e-05	0.000656	CcSEcCtD
Cabergoline—Discomfort—Prednisone—atopic dermatitis	9.38e-05	0.000656	CcSEcCtD
Cabergoline—Hypersensitivity—Prednisolone—atopic dermatitis	9.23e-05	0.000645	CcSEcCtD
Cabergoline—Dyspepsia—Dexamethasone—atopic dermatitis	9.2e-05	0.000643	CcSEcCtD
Cabergoline—Dyspepsia—Betamethasone—atopic dermatitis	9.2e-05	0.000643	CcSEcCtD
Cabergoline—Oedema—Prednisone—atopic dermatitis	9.11e-05	0.000637	CcSEcCtD
Cabergoline—Abdominal pain—Methylprednisolone—atopic dermatitis	9.09e-05	0.000635	CcSEcCtD
Cabergoline—Decreased appetite—Dexamethasone—atopic dermatitis	9.09e-05	0.000635	CcSEcCtD
Cabergoline—Decreased appetite—Betamethasone—atopic dermatitis	9.09e-05	0.000635	CcSEcCtD
Cabergoline—Hypersensitivity—Hydrocortisone—atopic dermatitis	9.02e-05	0.00063	CcSEcCtD
Cabergoline—Fatigue—Dexamethasone—atopic dermatitis	9.01e-05	0.00063	CcSEcCtD
Cabergoline—Fatigue—Betamethasone—atopic dermatitis	9.01e-05	0.00063	CcSEcCtD
Cabergoline—Shock—Prednisone—atopic dermatitis	8.96e-05	0.000626	CcSEcCtD
Cabergoline—Pain—Dexamethasone—atopic dermatitis	8.94e-05	0.000625	CcSEcCtD
Cabergoline—Pain—Betamethasone—atopic dermatitis	8.94e-05	0.000625	CcSEcCtD
Cabergoline—Hyperhidrosis—Prednisone—atopic dermatitis	8.8e-05	0.000615	CcSEcCtD
Cabergoline—Asthenia—Hydrocortisone—atopic dermatitis	8.78e-05	0.000614	CcSEcCtD
Cabergoline—Anorexia—Prednisone—atopic dermatitis	8.68e-05	0.000607	CcSEcCtD
Cabergoline—Pruritus—Hydrocortisone—atopic dermatitis	8.66e-05	0.000605	CcSEcCtD
Cabergoline—Feeling abnormal—Betamethasone—atopic dermatitis	8.62e-05	0.000602	CcSEcCtD
Cabergoline—Feeling abnormal—Dexamethasone—atopic dermatitis	8.62e-05	0.000602	CcSEcCtD
Cabergoline—Gastrointestinal pain—Betamethasone—atopic dermatitis	8.55e-05	0.000598	CcSEcCtD
Cabergoline—Gastrointestinal pain—Dexamethasone—atopic dermatitis	8.55e-05	0.000598	CcSEcCtD
Cabergoline—Hypersensitivity—Triamcinolone—atopic dermatitis	8.49e-05	0.000594	CcSEcCtD
Cabergoline—Hypersensitivity—Methylprednisolone—atopic dermatitis	8.47e-05	0.000592	CcSEcCtD
Cabergoline—Diarrhoea—Hydrocortisone—atopic dermatitis	8.37e-05	0.000585	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Prednisone—atopic dermatitis	8.3e-05	0.00058	CcSEcCtD
Cabergoline—Dizziness—Prednisolone—atopic dermatitis	8.29e-05	0.000579	CcSEcCtD
Cabergoline—Asthenia—Triamcinolone—atopic dermatitis	8.27e-05	0.000578	CcSEcCtD
Cabergoline—Abdominal pain—Betamethasone—atopic dermatitis	8.27e-05	0.000578	CcSEcCtD
Cabergoline—Abdominal pain—Dexamethasone—atopic dermatitis	8.27e-05	0.000578	CcSEcCtD
Cabergoline—Asthenia—Methylprednisolone—atopic dermatitis	8.25e-05	0.000577	CcSEcCtD
Cabergoline—Insomnia—Prednisone—atopic dermatitis	8.24e-05	0.000576	CcSEcCtD
Cabergoline—Paraesthesia—Prednisone—atopic dermatitis	8.18e-05	0.000572	CcSEcCtD
Cabergoline—Pruritus—Triamcinolone—atopic dermatitis	8.15e-05	0.00057	CcSEcCtD
Cabergoline—Pruritus—Methylprednisolone—atopic dermatitis	8.13e-05	0.000569	CcSEcCtD
Cabergoline—Dizziness—Hydrocortisone—atopic dermatitis	8.09e-05	0.000566	CcSEcCtD
Cabergoline—Dyspepsia—Prednisone—atopic dermatitis	8.02e-05	0.00056	CcSEcCtD
Cabergoline—Decreased appetite—Prednisone—atopic dermatitis	7.92e-05	0.000553	CcSEcCtD
Cabergoline—Rash—Prednisolone—atopic dermatitis	7.9e-05	0.000552	CcSEcCtD
Cabergoline—Dermatitis—Prednisolone—atopic dermatitis	7.89e-05	0.000552	CcSEcCtD
Cabergoline—Diarrhoea—Methylprednisolone—atopic dermatitis	7.87e-05	0.00055	CcSEcCtD
Cabergoline—Fatigue—Prednisone—atopic dermatitis	7.85e-05	0.000549	CcSEcCtD
Cabergoline—Headache—Prednisolone—atopic dermatitis	7.85e-05	0.000549	CcSEcCtD
Cabergoline—Constipation—Prednisone—atopic dermatitis	7.79e-05	0.000544	CcSEcCtD
Cabergoline—Vomiting—Hydrocortisone—atopic dermatitis	7.78e-05	0.000544	CcSEcCtD
Cabergoline—Rash—Hydrocortisone—atopic dermatitis	7.72e-05	0.000539	CcSEcCtD
Cabergoline—Dermatitis—Hydrocortisone—atopic dermatitis	7.71e-05	0.000539	CcSEcCtD
Cabergoline—Headache—Hydrocortisone—atopic dermatitis	7.67e-05	0.000536	CcSEcCtD
Cabergoline—Dizziness—Triamcinolone—atopic dermatitis	7.62e-05	0.000533	CcSEcCtD
Cabergoline—Dizziness—Methylprednisolone—atopic dermatitis	7.6e-05	0.000532	CcSEcCtD
Cabergoline—Feeling abnormal—Prednisone—atopic dermatitis	7.5e-05	0.000525	CcSEcCtD
Cabergoline—Asthenia—Dexamethasone—atopic dermatitis	7.5e-05	0.000524	CcSEcCtD
Cabergoline—Asthenia—Betamethasone—atopic dermatitis	7.5e-05	0.000524	CcSEcCtD
Cabergoline—Gastrointestinal pain—Prednisone—atopic dermatitis	7.45e-05	0.000521	CcSEcCtD
Cabergoline—Nausea—Prednisolone—atopic dermatitis	7.44e-05	0.00052	CcSEcCtD
Cabergoline—Pruritus—Betamethasone—atopic dermatitis	7.4e-05	0.000517	CcSEcCtD
Cabergoline—Pruritus—Dexamethasone—atopic dermatitis	7.4e-05	0.000517	CcSEcCtD
Cabergoline—Vomiting—Triamcinolone—atopic dermatitis	7.33e-05	0.000512	CcSEcCtD
Cabergoline—Vomiting—Methylprednisolone—atopic dermatitis	7.31e-05	0.000511	CcSEcCtD
Cabergoline—Nausea—Hydrocortisone—atopic dermatitis	7.27e-05	0.000508	CcSEcCtD
Cabergoline—Rash—Triamcinolone—atopic dermatitis	7.27e-05	0.000508	CcSEcCtD
Cabergoline—Dermatitis—Triamcinolone—atopic dermatitis	7.26e-05	0.000507	CcSEcCtD
Cabergoline—Rash—Methylprednisolone—atopic dermatitis	7.25e-05	0.000507	CcSEcCtD
Cabergoline—Dermatitis—Methylprednisolone—atopic dermatitis	7.24e-05	0.000506	CcSEcCtD
Cabergoline—Headache—Triamcinolone—atopic dermatitis	7.22e-05	0.000505	CcSEcCtD
Cabergoline—Headache—Methylprednisolone—atopic dermatitis	7.2e-05	0.000504	CcSEcCtD
Cabergoline—Abdominal pain—Prednisone—atopic dermatitis	7.2e-05	0.000503	CcSEcCtD
Cabergoline—Diarrhoea—Dexamethasone—atopic dermatitis	7.15e-05	0.0005	CcSEcCtD
Cabergoline—Diarrhoea—Betamethasone—atopic dermatitis	7.15e-05	0.0005	CcSEcCtD
Cabergoline—Dizziness—Betamethasone—atopic dermatitis	6.91e-05	0.000483	CcSEcCtD
Cabergoline—Dizziness—Dexamethasone—atopic dermatitis	6.91e-05	0.000483	CcSEcCtD
Cabergoline—Nausea—Triamcinolone—atopic dermatitis	6.84e-05	0.000479	CcSEcCtD
Cabergoline—Nausea—Methylprednisolone—atopic dermatitis	6.83e-05	0.000477	CcSEcCtD
Cabergoline—Hypersensitivity—Prednisone—atopic dermatitis	6.71e-05	0.000469	CcSEcCtD
Cabergoline—Vomiting—Dexamethasone—atopic dermatitis	6.65e-05	0.000465	CcSEcCtD
Cabergoline—Vomiting—Betamethasone—atopic dermatitis	6.65e-05	0.000465	CcSEcCtD
Cabergoline—Rash—Dexamethasone—atopic dermatitis	6.59e-05	0.000461	CcSEcCtD
Cabergoline—Rash—Betamethasone—atopic dermatitis	6.59e-05	0.000461	CcSEcCtD
Cabergoline—Dermatitis—Betamethasone—atopic dermatitis	6.59e-05	0.00046	CcSEcCtD
Cabergoline—Dermatitis—Dexamethasone—atopic dermatitis	6.59e-05	0.00046	CcSEcCtD
Cabergoline—Headache—Dexamethasone—atopic dermatitis	6.55e-05	0.000458	CcSEcCtD
Cabergoline—Headache—Betamethasone—atopic dermatitis	6.55e-05	0.000458	CcSEcCtD
Cabergoline—Asthenia—Prednisone—atopic dermatitis	6.53e-05	0.000457	CcSEcCtD
Cabergoline—Pruritus—Prednisone—atopic dermatitis	6.44e-05	0.00045	CcSEcCtD
Cabergoline—Diarrhoea—Prednisone—atopic dermatitis	6.23e-05	0.000436	CcSEcCtD
Cabergoline—Nausea—Betamethasone—atopic dermatitis	6.21e-05	0.000434	CcSEcCtD
Cabergoline—Nausea—Dexamethasone—atopic dermatitis	6.21e-05	0.000434	CcSEcCtD
Cabergoline—Dizziness—Prednisone—atopic dermatitis	6.02e-05	0.000421	CcSEcCtD
Cabergoline—Vomiting—Prednisone—atopic dermatitis	5.79e-05	0.000405	CcSEcCtD
Cabergoline—Rash—Prednisone—atopic dermatitis	5.74e-05	0.000401	CcSEcCtD
Cabergoline—Dermatitis—Prednisone—atopic dermatitis	5.74e-05	0.000401	CcSEcCtD
Cabergoline—Headache—Prednisone—atopic dermatitis	5.7e-05	0.000399	CcSEcCtD
Cabergoline—Nausea—Prednisone—atopic dermatitis	5.41e-05	0.000378	CcSEcCtD
Cabergoline—DRD4—Signaling Pathways—NGF—atopic dermatitis	1.2e-05	0.000159	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL5—atopic dermatitis	1.2e-05	0.000159	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—CXCL8—atopic dermatitis	1.19e-05	0.000159	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—IL2—atopic dermatitis	1.19e-05	0.000159	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CXCL10—atopic dermatitis	1.19e-05	0.000158	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	1.18e-05	0.000158	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	1.18e-05	0.000157	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.18e-05	0.000157	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL5—atopic dermatitis	1.18e-05	0.000157	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.17e-05	0.000155	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.17e-05	0.000155	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CCR5—atopic dermatitis	1.17e-05	0.000155	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CCL5—atopic dermatitis	1.17e-05	0.000155	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	1.16e-05	0.000155	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	1.16e-05	0.000154	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	1.16e-05	0.000154	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	1.15e-05	0.000154	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	1.15e-05	0.000154	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	1.15e-05	0.000154	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CCL5—atopic dermatitis	1.15e-05	0.000153	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CCL5—atopic dermatitis	1.15e-05	0.000153	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—NGF—atopic dermatitis	1.14e-05	0.000152	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—IL2—atopic dermatitis	1.14e-05	0.000152	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	1.14e-05	0.000152	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	1.13e-05	0.000151	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	1.13e-05	0.00015	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	1.13e-05	0.00015	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	1.12e-05	0.000148	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—IL2—atopic dermatitis	1.12e-05	0.000148	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	1.11e-05	0.000148	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	1.11e-05	0.000147	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	1.09e-05	0.000145	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—NGF—atopic dermatitis	1.08e-05	0.000144	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	1.07e-05	0.000143	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	1.07e-05	0.000143	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.07e-05	0.000142	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—NGF—atopic dermatitis	1.06e-05	0.000142	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—NGF—atopic dermatitis	1.06e-05	0.000142	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.06e-05	0.000142	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	1.06e-05	0.000141	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.06e-05	0.000141	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.05e-05	0.00014	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CCR5—atopic dermatitis	1.05e-05	0.00014	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	1.05e-05	0.000139	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.04e-05	0.000138	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	1.04e-05	0.000138	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CCR5—atopic dermatitis	1.04e-05	0.000138	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CCR5—atopic dermatitis	1.04e-05	0.000138	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—NFKBIA—atopic dermatitis	1.03e-05	0.000137	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—IL2—atopic dermatitis	1.03e-05	0.000137	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	1.03e-05	0.000137	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CCL5—atopic dermatitis	1.02e-05	0.000136	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.02e-05	0.000136	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	1.02e-05	0.000136	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.02e-05	0.000135	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	1.02e-05	0.000135	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—IL2—atopic dermatitis	1.01e-05	0.000135	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	1.01e-05	0.000135	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	1.01e-05	0.000135	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	1.01e-05	0.000134	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	1.01e-05	0.000134	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	1e-05	0.000134	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	1e-05	0.000133	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—PPARA—atopic dermatitis	1e-05	0.000133	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	9.97e-06	0.000133	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—IL2—atopic dermatitis	9.94e-06	0.000132	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	9.89e-06	0.000132	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	9.85e-06	0.000131	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	9.84e-06	0.000131	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	9.72e-06	0.000129	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—NGF—atopic dermatitis	9.7e-06	0.000129	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	9.7e-06	0.000129	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	9.69e-06	0.000129	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	9.67e-06	0.000129	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	9.66e-06	0.000129	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	9.61e-06	0.000128	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	9.57e-06	0.000127	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—CXCL8—atopic dermatitis	9.55e-06	0.000127	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	9.54e-06	0.000127	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—NGF—atopic dermatitis	9.49e-06	0.000126	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—CXCL8—atopic dermatitis	9.45e-06	0.000126	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	9.44e-06	0.000126	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	9.44e-06	0.000126	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	9.41e-06	0.000125	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	9.35e-06	0.000124	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—NGF—atopic dermatitis	9.28e-06	0.000123	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	9.26e-06	0.000123	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	9.24e-06	0.000123	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CCR5—atopic dermatitis	9.23e-06	0.000123	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—NGF—atopic dermatitis	9.23e-06	0.000123	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	9.23e-06	0.000123	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	9.19e-06	0.000122	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	9.15e-06	0.000122	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	9.15e-06	0.000122	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—IL2—atopic dermatitis	9.13e-06	0.000121	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—IL6—atopic dermatitis	9.08e-06	0.000121	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—IL2—atopic dermatitis	9.03e-06	0.00012	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	9.03e-06	0.00012	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	8.98e-06	0.000119	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	8.98e-06	0.000119	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	8.94e-06	0.000119	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	8.93e-06	0.000119	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	8.9e-06	0.000118	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	8.84e-06	0.000118	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	8.83e-06	0.000117	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	8.8e-06	0.000117	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CCL5—atopic dermatitis	8.8e-06	0.000117	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	8.79e-06	0.000117	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	8.78e-06	0.000117	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	8.78e-06	0.000117	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	8.78e-06	0.000117	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	8.73e-06	0.000116	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	8.66e-06	0.000115	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	8.61e-06	0.000114	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	8.6e-06	0.000114	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	8.54e-06	0.000114	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	8.54e-06	0.000114	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	8.48e-06	0.000113	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	8.41e-06	0.000112	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—MAPK8—atopic dermatitis	8.4e-06	0.000112	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	8.4e-06	0.000112	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	8.22e-06	0.000109	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—NGF—atopic dermatitis	8.15e-06	0.000108	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PPARA—atopic dermatitis	8.13e-06	0.000108	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	8.11e-06	0.000108	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—NGF—atopic dermatitis	8.02e-06	0.000107	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	8e-06	0.000106	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	8e-06	0.000106	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	7.98e-06	0.000106	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	7.93e-06	0.000105	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CCR5—atopic dermatitis	7.93e-06	0.000105	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	7.87e-06	0.000105	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	7.85e-06	0.000104	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—NFKBIA—atopic dermatitis	7.83e-06	0.000104	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	7.81e-06	0.000104	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	7.8e-06	0.000104	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL2—atopic dermatitis	7.75e-06	0.000103	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	7.65e-06	0.000102	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	7.64e-06	0.000102	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	7.64e-06	0.000102	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	7.63e-06	0.000101	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	7.61e-06	0.000101	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	7.47e-06	9.94e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	7.4e-06	9.85e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	7.36e-06	9.8e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	7.32e-06	9.73e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	7.29e-06	9.7e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	7.29e-06	9.7e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	7.26e-06	9.66e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	7.16e-06	9.53e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	7.09e-06	9.44e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	7.05e-06	9.38e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL2—atopic dermatitis	7.04e-06	9.36e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—IL6—atopic dermatitis	7e-06	9.32e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL2—atopic dermatitis	6.99e-06	9.3e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	6.96e-06	9.26e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	6.94e-06	9.23e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL2—atopic dermatitis	6.85e-06	9.11e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	6.81e-06	9.06e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL2—atopic dermatitis	6.74e-06	8.96e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	6.73e-06	8.95e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	6.72e-06	8.94e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—IL6—atopic dermatitis	6.7e-06	8.92e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	6.61e-06	8.8e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	6.48e-06	8.62e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	6.47e-06	8.61e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	6.44e-06	8.56e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL2—atopic dermatitis	6.43e-06	8.56e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	6.4e-06	8.51e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	6.35e-06	8.44e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	6.3e-06	8.38e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	6.26e-06	8.33e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	6.26e-06	8.33e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	6.2e-06	8.25e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL2—atopic dermatitis	6.07e-06	8.07e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—IL6—atopic dermatitis	6.03e-06	8.03e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	6.01e-06	8e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL2—atopic dermatitis	5.98e-06	7.96e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	5.98e-06	7.96e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—IL6—atopic dermatitis	5.95e-06	7.92e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	5.95e-06	7.92e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	5.92e-06	7.88e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	5.71e-06	7.59e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	5.65e-06	7.52e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	5.58e-06	7.43e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CXCL8—atopic dermatitis	5.58e-06	7.43e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	5.51e-06	7.33e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	5.51e-06	7.33e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	5.46e-06	7.26e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL2—atopic dermatitis	5.45e-06	7.25e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	5.43e-06	7.22e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	5.43e-06	7.22e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	5.4e-06	7.19e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	5.38e-06	7.15e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—IL6—atopic dermatitis	5.37e-06	7.14e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL2—atopic dermatitis	5.33e-06	7.1e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—IL6—atopic dermatitis	5.31e-06	7.06e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	5.28e-06	7.03e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL2—atopic dermatitis	5.22e-06	6.94e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	5.2e-06	6.91e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	5.19e-06	6.9e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL2—atopic dermatitis	5.19e-06	6.9e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	5.16e-06	6.87e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	5.05e-06	6.71e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	5.02e-06	6.68e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	5.02e-06	6.68e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	4.97e-06	6.62e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	4.97e-06	6.61e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	4.94e-06	6.58e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MAPK8—atopic dermatitis	4.91e-06	6.53e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	4.8e-06	6.39e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	4.79e-06	6.38e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	4.78e-06	6.35e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	4.71e-06	6.27e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	4.65e-06	6.18e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	4.62e-06	6.14e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL2—atopic dermatitis	4.58e-06	6.09e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	4.57e-06	6.08e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL6—atopic dermatitis	4.56e-06	6.06e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL2—atopic dermatitis	4.51e-06	5.99e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	4.48e-06	5.96e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	4.41e-06	5.87e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	4.39e-06	5.84e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	4.29e-06	5.71e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	4.21e-06	5.61e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	4.15e-06	5.52e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL6—atopic dermatitis	4.14e-06	5.5e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL6—atopic dermatitis	4.11e-06	5.47e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	4.1e-06	5.45e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	4.08e-06	5.43e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	4.06e-06	5.4e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL6—atopic dermatitis	4.02e-06	5.35e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL6—atopic dermatitis	3.96e-06	5.27e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL6—atopic dermatitis	3.78e-06	5.03e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	3.77e-06	5.02e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL6—atopic dermatitis	3.56e-06	4.74e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	3.52e-06	4.68e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL6—atopic dermatitis	3.52e-06	4.68e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARA—atopic dermatitis	3.47e-06	4.61e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL6—atopic dermatitis	3.2e-06	4.26e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	3.18e-06	4.23e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL6—atopic dermatitis	3.14e-06	4.17e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL6—atopic dermatitis	3.07e-06	4.08e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL6—atopic dermatitis	3.05e-06	4.06e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	2.97e-06	3.95e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	2.92e-06	3.88e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6—atopic dermatitis	2.69e-06	3.58e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6—atopic dermatitis	2.65e-06	3.52e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	2.59e-06	3.45e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	2.41e-06	3.21e-05	CbGpPWpGaD
